Clotrimazole Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%)
Condition:   HIV- Prevention Interventions:   Drug: Dapivirine Ring-004;   Drug: Dapivirine Ring-004 for 28 days along with clotrimazole;   Drug: Clotrimazole Sponsor:   International Partnership for Microbicides, Inc. Active, not recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2016 Category: Research Source Type: clinical trials

To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%)
< b > Condition < /b > :   HIV- Prevention < br/ > < b > Interventions < /b > :   Drug: Dapivirine Ring-004;   Drug: Dapivirine Ring-004 for 28 days along with clotrimazole;   Drug: Clotrimazole < br/ > < b > Sponsor < /b > :   International Partnership for Microbicides, Inc. < br/ > < b > Active, not recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2016 Category: Research Source Type: clinical trials

To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%)
Condition:   HIV- Prevention Interventions:   Drug: Dapivirine Ring-004;   Drug: Dapivirine Ring-004 for 28 days along with clotrimazole;   Drug: Clotrimazole Sponsor:   International Partnership for Microbicides, Inc. Active, not recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2016 Category: Research Source Type: clinical trials

To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%)
< b > Condition < /b > :   HIV- Prevention < br/ > < b > Interventions < /b > :   Drug: Dapivirine Ring-004;   Drug: Dapivirine Ring-004 for 28 days along with clotrimazole;   Drug: Clotrimazole < br/ > < b > Sponsor < /b > :   International Partnership for Microbicides, Inc. < br/ > < b > Active, not recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2016 Category: Research Source Type: clinical trials

To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%)
Condition:   HIV- PreventionInterventions:   Drug: Dapivirine Ring-004;   Drug: Dapivirine Ring-004 for 28 days along with clotrimazole;   Drug: ClotrimazoleSponsor:   International Partnership for Microbicides, Inc.Active, not recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2016 Category: Research Source Type: clinical trials